glp 1 sglt2 GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview – AJKD Blog GLP-1 RA and SGLT2 Inhibitors:

Distinct from prior reviews that predominantly focus on a single drug class or limited clinical indications, this article systematically contrasts the mechanistic pathways, therapeutic efficacy, and safety profiles of GLP-1RAs versus GLP-1/GIP dual receptor agonists

Together, along with electrolytes, Ora says these are science-backed supplements that act as your GLP-1 sidekick, helping you navigate the challenges while maximizing the benefits. Because strength training is recommended while taking a GLP-1, Ora is contributing to this area of concern with its flavorful protein powder

Circulation 109(13):15941602

Extensive research is currently underway on the effects of these drugs with GLP-1RA properties in brain diseases

Conflict of interest: MH has provided consultancy services to AstraZeneca, Novo Nordisk, Merck & Co., and HoffmanLa Roche with respect to incretin-targeted therapeutics and has received investigator-initiated research grants from Novo Nordisk and Merck & Co